Global Hereditary Testing Industry: A Latest Research Report to Share Market Insights and Dynamics
The global hereditary testing market expected to reach USD 9.29 billion by 2027 according to a new study by Polaris Market Research. The report “Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing, Hereditary Non-Cancer Testing; By Technology (Cytogenetic, Biochemical, Molecular Testing); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing need for timely diagnosis of genetic hereditary diseases and launch of cost-effective treatment options by the key players are the key factors responsible for market growth. According to the market statistics published by the organization dedicated for the rare diseases, over 300 million people are currently suffering from around 6,000 identified forms of rare disorders worldwide.
Technological advancements in the marketspace and use of cloud-based distribution model for laboratories to avail the bioinformatics is expected to have a positive impact on the hereditary testing growth. Furthermore, the increasing test volumes for genetic tests across the developed economies is expected to drive market demand for hereditary testing over the forecast period.
Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market/request-for-sample
Segment Highlights
- The hereditary cancer testing market segment accounted for the largest revenue segment in 2019 owing to the increasing genetic tests for cancer in developed economies such as the U.S., UK, Canada, and France, among others
- Europe market accounted for the largest revenue share in 2019 owing to the increasing tests across the region and technological advancement in the field of testing is expected to drive the market growth of hereditary tests over the forecast period
List of Key Players
- Myriad Genetics, Inc.
- Invitae Corporation
- Illumina, Inc.
- Natera, Inc.
- Hoffmann-La Roche Ltd
- Quest Diagnostics
- Agilent Technologies, Inc.
- Twist Bioscience
- Sophia Genetics
- Fulgent Genetic, Inc.
- Medgenome
- CENTOGENE N.V.
- Others
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market/speak-to-analyst
Polaris Market Research has segmented the hereditary testing market report on the basis of disease type, technology, and region
Hereditary Testing, Disease Type Outlook (Revenue – USD Million, 2016 – 2027)
- Hereditary Cancer Testing
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Ovarian Cancer
- Prostate Cancer
- Stomach/Gastric Cancer
- Melanoma
- Sarcoma
- Uterine Cancer
- Pancreatic Cancer
- Others
- Hereditary Non-Cancer Testing
- Genetic Tests
- Cardiac Diseases
- Rare Diseases
- Other Diseases
- Newborn Genetic Screening
- Preimplantation Genetic Diagnosis & Screening
- Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
Hereditary Testing, Technology Outlook (Revenue – USD Million, 2016 – 2027)
- Cytogenetic Testing
- Biochemical Testing
- Molecular Testing
Hereditary Testing Regional Outlook (Revenue – USD Million, 2016 – 2027)
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
- Latin America (Brazil, Mexico, Argentina)
- MEA (Saudi Arabia, UAE, Israel, South Africa)
